Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival

The targeted delivery of therapeutic drugs to lymph nodes (LNs) provides an unprecedented opportunity to improve the outcomes of transplantation and immune-mediated diseases. The high endothelial venule is a specialized segment of LN vasculature that uniquely expresses peripheral node addressin (PNAd) molecules. PNAd is recognized by MECA79 mAb. We previously generated a MECA79 mAb–coated microparticle (MP) that carries tacrolimus. Although this MP trafficked to LNs, it demonstrated limited therapeutic efficacy in our transplant model. Here, we have synthesized a nanoparticle (NP) as a carrier of anti-CD3, and optimized the conjugation strategy to coat the NP surface with MECA79 mAb (MECA79-anti-CD3-NP) to enhance LN accumulation. As compared with nonconjugated NPs, a significantly higher quantity of MECA79-NPs accumulated in the draining lymph node (DLN). Many MECA79-NPs underwent internalization by T cells and dendritic cells within the LNs. Short-term treatment of murine cardiac allograft recipients with MECA79-anti-CD3-NP resulted in significantly prolonged allograft survival in comparison with the control groups. Prolonged graft survival following treatment with MECA79-anti-CD3-NP was characterized by a significant increase in intragraft and DLN Treg populations. Treg depletion abrogated the prolongation of heart allograft survival. We believe this targeted approach of drug delivery could redefine the methods of administering immune therapeutics in transplantation.

• Publication year

  2018

• Venue

  Journal of Clinical Investigation

• Publication date

  2018-10-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1172/JCI120923PMID 30277476PMCID PMC6205374
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Material design for lymph node drug delivery

  2019cited by this paper
• Nanodelivery Of Mycophenolate Mofetil To The Organ Improves Transplant Vasculopathy.

  2019cited by this paper
• Active targeted delivery of immune therapeutics to lymph nodes

  2017cited by this paper
• Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses.

  2017cited by this paper
• Targeted Delivery of Immunomodulators to Lymph Nodes

  2016cited by this paper
• Antibody fragments as nanoparticle targeting ligands: a step in the right direction

  2016cited by this paper
• 3D Structural Fluctuation of IgG1 Antibody Revealed by Individual Particle Electron Tomography

  2015cited by this paper
• Principles of nanoparticle design for overcoming biological barriers to drug delivery

  2015cited by this paper
• Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.

  2015cited by this paper
• Harnessing nanoparticles for immune modulation

  2015cited by this paper
• A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease

  2014cited by this paper
• Factors influencing long‐term outcome after kidney transplantation

  2014cited by this paper
• Laminins affect T cell trafficking and allograft fate.

  2014cited by this paper
• Structure-based programming of lymph-node targeting in molecular vaccines

  2014cited by this paper
• Delayed Anti-CD3 Therapy Results in Depletion of Alloreactive T Cells and the Dominance of Foxp3+CD4+ Graft Infiltrating Cells

  2013cited by this paper
• A modified heterotopic swine hind limb transplant model for translational vascularized composite allotransplantation (VCA) research.

  2013cited by this paper
• Methods for conjugating antibodies to nanocarriers.

  2013cited by this paper
• Developments and Challenges for mAb-Based Therapeutics

  2013cited by this paper
• Anatomy of tolerance

  2013cited by this paper
• Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation

  2012cited by this paper
• Antibody Induction Therapy in Renal Transplant Patients Receiving Calcineurin-Inhibitor Immunosuppressive Regimens

  2012cited by this paper
• Disulfide bond structures of IgG molecules

  2012cited by this paper
• Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance

  2011cited by this paper
• Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival.

  2011cited by this paper
• In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles

  2011cited by this paper
• Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells

  2011cited by this paper
• Tolerance and Lymphoid Organ Structure and Function

  2011cited by this paper
• Active tumor targeting of nanomaterials using folic acid, transferrin and integrin receptors.

  2011cited by this paper
• 'Actively acquired tolerance' of foreign cells. 1953.

  2010cited by this paper
• Receptor-targeted nanocarriers for therapeutic delivery to cancer

  2010cited by this paper
• Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti‐T‐lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction

  2010cited by this paper
• 'Actively acquired tolerance' of foreign cells. 1953.

  2010cited by this paper
• Materials engineering for immunomodulation

  2009cited by this paper
• Malignancy after kidney transplantation: results of 400 patients from a single center

  2008cited by this paper
• Tumour-targeted nanomedicines: principles and practice

  2008cited by this paper
• Pharmacokinetics and biodistribution of nanoparticles.

  2008cited by this paper
• CD3-specific antibodies: a portal to the treatment of autoimmunity

  2007cited by this paper
• Renal clearance of quantum dots

  2007cited by this paper
• In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.

  2007cited by this paper
• Nanocarriers as an emerging platform for cancer therapy.

  2007cited by this paper
• Kidney and Pancreas Transplantation in the United States, 1996–2005

  2007cited by this paper
• Exploiting lymphatic transport and complement activation in nanoparticle vaccines

  2007cited by this paper
• Sulfated L-selectin ligands as a therapeutic target in chronic inflammation.

  2006cited by this paper
• Targeting dendritic cells with biomaterials: developing the next generation of vaccines.

  2006cited by this paper
• Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.

  2006cited by this paper
• Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice

  2006cited by this paper
• N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules

  2005cited by this paper
• A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules

  2005cited by this paper
• Strategies for minimizing immunosuppression in kidney transplantation

  2005cited by this paper
• TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.

  2005cited by this paper
• Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.

  2005cited by this paper
• IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains.

  2005cited by this paper
• Immunosuppressive drugs for kidney transplantation.

  2004cited by this paper
• Immunosuppression and the Risk of Post‐Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients

  2004cited by this paper
• Transplantation tolerance: a journey from ignorance to memory.

  2003cited by this paper
• The Strategy of T Cell Antigen-presenting Cell Encounter in Antigen-draining Lymph Nodes Revealed by Imaging of Initial T Cell Activation

  2003cited by this paper
• 'Actively acquired tolerance' of foreign cells. 1953.

  2003cited by this paper
• CD3-specific antibody-induced active tolerance: from bench to bedside

  2003cited by this paper
• One technique, two approaches, and results: Thoracic duct cannulation in small laboratory animals

  2003cited by this paper
• L-Selectin-Dependent Lymphoid Occupancy Is Required to Induce Alloantigen-Specific Tolerance1

  2002cited by this paper
• Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

  2002cited by this paper
• Structural requirements for incorporation of J chain into human IgM and IgA.

  2000cited by this paper
• Unusual gingival presentation of post-transplantation lymphoproliferative disorder: a case report and review of the literature.

  2000cited by this paper
• T-cell function and migration. Two sides of the same coin.

  2000cited by this paper
• Impact of acute rejection therapy on infections and malignancies in renal transplant recipients.

  1999cited by this paper
• Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review.

  1995cited by this paper
• The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor

  1991cited by this paper
• SELECTIVE REDUCTION OF DISULFIDES BY TRIS(2-CARBOXYETHYL) PHOSPHINE

  1991cited by this paper
• Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone.

  1991cited by this paper
• Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation

  1990cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper
• Detection of circulating tumor necrosis factor after endotoxin administration.

  1988cited by this paper
• Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.

  1988cited by this paper
• Reduction of the buried intrachain disulfide bond of the constant fragment of the immunoglobulin light chain: global unfolding under physiological conditions.

  1986cited by this paper
• Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins

  1984cited by this paper
• Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.

  1981cited by this paper
• Three-dimensional structure of immunoglobulins.

  1979cited by this paper
• Heart transplantation in congenic strains of mice.

  1973cited by this paper
• Disulfide Bonds of Human IgM: Differential Sensitivity to Reductive Cleavage

  1973cited by this paper

• Nanomedicine meets transplantation: Unlocking precision therapeutics for organ rejection

  2026cites this paper
• Nanoassembly-mediated immunometabolic reprogramming of CD4+ T cells suppresses β-cell autoimmunity in type 1 diabetes.

  2026cites this paper
• Inhibition of CD154:CD11b interactions using a novel nanotherapeutic improves allograft survival.

  2026cites this paper
• Engineering Lymphatic Transport of Nanoparticles through Emulsion Polymerization

  2025cites this paper
• CXCL12+ fibroblastic reticular cells in lymph nodes facilitate immune tolerance by regulating T cell–mediated alloimmunity

  2025cites this paper
• Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity.

  2025cites this paper
• The effect of proteasome in heart transplantation: From mechanisms to therapeutic potential.

  2025cites this paper
• Regulatory Immune Cell-derived Exosomes: Modes of Action and Therapeutic Potential in Transplantation.

  2025cites this paper
• Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation

  2025cites this paper
• Recent progress of nanomaterials for diagnosis and treatment of rejection in heart transplantation

  2025cites this paper
• A novel FK506-loading mesoporous silica nanoparticle homing to lymph nodes for transplant rejection treatment.

  2024cites this paper
• Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors.

  2024cites this paper
• Nanoparticle-based T cell immunoimaging and immunomodulatory for diagnosing and treating transplant rejection

  2024cites this paper
• Rapid Generation of hPSC‐Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities

  2024cites this paper
• Different leukocyte subsets are targeted by systemic and locoregional administration despite conserved nanomaterial characteristics optimal for lymph node delivery

  2024cites this paper
• Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions

  2024cites this paper
• Drug delivery strategies for local immunomodulation in transplantation: Bridging the translational gap.

  2024cites this paper
• Nanotechnology-based Strategies for Molecular Imaging, Diagnosis, and Therapy of Organ Transplantation.

  2024cites this paper
• Hybrid nanovesicles comprising induced pluripotent stem cells and dendritic cell-derived exosomes enhance antitumor immunity

  2024cites this paper
• Immunotherapy of Diseases and Nanotechnology: Current State and Prospects

  2024cites this paper
• Alternative Therapies in Transplantology as a Promising Perspective in Medicine

  2024cites this paper
• Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery.

  2024cites this paper
• Nanoparticle-assisted Targeting Delivery Technologies for Preventing Organ Rejection.

  2024cites this paper
• Targeted modulation of immune cells and tissues using engineered biomaterials.

  2023cites this paper
• Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases.

  2023cites this paper
• The immunoregulatory roles of non-haematopoietic cells in the kidney

  2023cites this paper
• Regulation, Maintenance, and Remodeling of High Endothelial Venules in Homeostasis, Inflammation, and Cancer.

  2023cites this paper
• Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes

  2023cites this paper
• Ex vivo intranodal administration of sirolimus.

  2023cites this paper
• CaCO3 powder-mediated biomineralization of antigen nanosponges synergize with PD-1 blockade to potentiate anti-tumor immunity

  2023cites this paper
• Immunomodulatory nanosystems: An emerging strategy to combat viral infections

  2023cites this paper
• Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines.

  2022cites this paper
• Characterization of Leptin Receptor+ Stromal Cells in Lymph Node

  2022cites this paper
• Nanotherapeutics in transplantation: How do we get to clinical implementation?

  2022cites this paper
• Emerging local immunomodulatory strategies to circumvent systemic immunosuppression in cell transplantation

  2022influential citation
• Liposomes are Poorly Absorbed via Lung Lymph After Inhaled Administration in Sheep

  2022cites this paper
• High endothelial venules as potential gateways for therapeutics.

  2022cites this paper
• Rapamycin-encapsulated costimulatory ICOS/CD40L-bispecific nanoparticles restrict pathogenic helper T-B-cell interactions while in situ suppressing mTOR for lupus treatment.

  2022cites this paper
• Lymph‐Node‐Targeted Drug Delivery for Effective Immunomodulation to Prolong the Long‐Term Survival After Heart Transplantation

  2022cites this paper
• Locoregional Lymphatic Delivery Systems Using Nanoparticles and Hydrogels for Anticancer Immunotherapy

  2022cites this paper
• Immunomodulatory nano-preparations for rheumatoid arthritis

  2022cites this paper
• Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice

  2022cites this paper
• Lipid nanoparticles technology in vaccines: Shaping the future of prophylactic medicine.

  2022cites this paper
• Immunosuppressive effect of PLGA-FK506-NPs in treatment of acute cardiac rejection via topical subcutaneous injection

  2021cites this paper
• ACTH treatment promotes murine cardiac allograft acceptance

  2021cites this paper
• Targeting peripheral immune organs with self‐assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection

  2021cites this paper
• Nanoparticle-based approaches to target the lymphatic system for antitumor treatment

  2021cites this paper
• Targeted delivery of mycophenolic acid to the mesenteric lymph node using a triglyceride mimetic prodrug approach enhances gut-specific immunomodulation in mice.

  2021cites this paper
• Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

  2021cites this paper
• Innovations in lymph node targeting nanocarriers.

  2021cites this paper
• Modulation of Leukocytes of the Innate Arm of the Immune System as a Potential Approach to Prevent the Onset and Progression of Type 1 Diabetes

  2021cites this paper
• Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery.

  2021cites this paper
• Vascular Endothelial Cells: Heterogeneity and Targeting Approaches

  2021cites this paper
• Designing spatial and temporal control of vaccine responses

  2021cites this paper
• Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy.

  2020cites this paper
• Nanoparticle Platforms for Antigen-Specific Immune Tolerance

  2020cites this paper
• Tolerizing Strategies for the Treatment of Autoimmune Diseases: From ex vivo to in vivo Strategies

  2020cites this paper
• Regulatory T cells in solid organ transplantation

  2020cites this paper
• Tolerogenic dendritic cells in organ transplantation

  2020cites this paper
• Lymph node fibroblastic reticular cells deposit fibrosis-associated collagen following organ transplantation.

  2020cites this paper
• Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy.

  2020cites this paper
• Local immunosuppression in vascularized composite allotransplantation (VCA): A systematic review.

  2020cites this paper
• Leveraging the Modularity of Biomaterial Carriers to Tune Immune Responses

  2020cites this paper
• Lymph-directed nitric oxide increases immune cell access to lymph-borne nanoscale solutes.

  2020cites this paper
• Manipulation of Regulatory Dendritic Cells for Induction Transplantation Tolerance

  2020cites this paper
• Lymph-directed immunotherapy - Harnessing endogenous lymphatic distribution pathways for enhanced therapeutic outcomes in cancer.

  2020cites this paper
• Metabolic Optimisation of Regulatory T Cells in Transplantation

  2020cites this paper
• Target-oriented delivery of self-assembled immunosuppressant cocktails prolongs allogeneic orthotopic liver transplant survival.

  2020cites this paper
• Cellular Mechanisms of Rejection of Optic and Sciatic Nerve Transplants: An Observational Study

  2020cites this paper
• Lymphatic vessels in solid organ transplantation and immunobiology

  2020cites this paper
• Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration

  2019cites this paper
• Targeted Migration of Human Adipose‐Derived Stem Cells to Secondary Lymphoid Organs Enhances Their Immunomodulatory Effect and Prolongs the Survival of Allografted Vascularized Composites

  2019cites this paper
• Procurement and Transplantation of Abdominal Organs in Clinical Practice

  2019cites this paper
• Lymphatic changes in cancer and drug delivery to the lymphatics in solid tumors.

  2019cites this paper
• Kidney Transplantation

  2019cites this paper
• Delivery of FK506-loaded PLGA nanoparticles prolongs cardiac allograft survival.

  2019cites this paper
• Nanodelivery Of Mycophenolate Mofetil To The Organ Improves Transplant Vasculopathy.

  2019cites this paper
• Material design for lymph node drug delivery

  2019cites this paper
• Immunomodulatory Nanosystems

  2019cites this paper
• Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery

  2018cites this paper